National Cannabis REIT (NCR) is a diversified real estate development and property management company.
Our focus and mission is in the Legal Medical / Recreational Cannabis / Hemp Industries.
Through our integrated  business model and our operating subsidiaries, National Cannabis REIT is able to manage the full life cycle of real estate investment and property management in this space. 
National Cannabis REIT 's aim is to become a leader in providing properties specifically zoned for growing, distribution, R&D, as well as the sales and distribution of legalized cannabis and hemp, in both medical and recreational apporved states.  Our verticle business model includes property leasing, property acquisition, and acquiring technologically advanced machinery and equipment for cannabis related research and development as well as providing capital for acquisition.

Nine Keys to a Successful Lease Agreement

Instructions for Form 8996
(Rev. December 2018)
Qualified Opportunity Fund

Download

N-2 Registration statement for closed-end management investment companies (PDF) 
Dec. 2018-SEC1716

Download

Our Company
We are a newly-formed, self-advised Maryland corporation focused on the acquisition, ownership and management of specialized industrial properties leased to experienced, state-licensed operators for their regulated medical-use cannabis facilities. Initially, we intend to acquire our properties through sale-leaseback transactions and third-party purchases.
We expect to lease our properties on a triple-net lease basis, where the tenant is responsible for all aspects of and costs related to the property and its operation during the lease term, including structural repairs, maintenance, taxes and insurance.
We intend to elect and to operate our business so as to qualify to be taxed as a REIT for U.S. federal income tax purposes.

For tax purposes, dividends are allocated to ordinary income, capital gains, and return of capital.
As REITs do not pay taxes at the corporate level, investors are taxed at their individual tax rate for the ordinary income
portion of the dividend.

We do not currently own any properties. We plan to finance our growth through the application of the net proceeds of this offering, and, when necessary, through additional equity and debt offerings. We currently anticipate that the average size of our investments will range from $5 million to $50 million and will involve between 25,000 and 300,000 square feet of space.

This is our initial public offering. We are selling 50,000 (Fifty-Thousand) shares of our Class A common stock.
We expect the initial public offering price of our Class A common stock to be $1000.00 per share. Prior to this offering, no public market exists for our shares.

We have been approved to list our shares of Class A common stock on the ATS Platform iNCUBANKER.com, subject to official notice of issuance, under the symbol “NACR.”

We have been organized and we intend to elect, and to operate our business so as to qualify and to be taxed as a real estate investment trust for U.S. federal income tax purposes, or REIT, commencing with our taxable year ending December 31, 2019 or, if later, the first year in which we have material real estate assets and operations. Shares of our Class A common stock will be subject to restrictions on ownership and transfer that are intended, among other purposes, to assist us in qualifying and maintaining our qualification as a REIT.

We are an “emerging growth company” under federal securities laws and will be subject to reduced public company reporting requirements. Investing in our Class A common stock involves a high degree of risk. You should purchase our Class A common stock only if you can afford a complete loss of your investment. See the section entitled “Risk Factors”.

For a discussion of the risks you should consider before buying shares of our Class A common stock.
Some of these risks include:

• We were recently formed, have no operating history and may not be able to operate our business successfully or generate sufficient cash flow to make or sustain distributions to our stockholders.

• We do not currently own any properties. We have identified only one property to acquire and have not entered into binding contracts or commitments to acquire any other specific properties or committed a substantial portion of the net proceeds of
this offering to any other specific investment in medical-use cannabis facilities. Investors will not be able to evaluate the economic merits of investments we make with a substantial portion of the net proceeds of this offering before purchasing our Class A common stock.

• We may be unable to invest the proceeds of this offering on acceptable terms, or at all.

• Medical-use cannabis remains illegal under federal law, and therefore, strict enforcement of federal laws regarding medical-use cannabis would likely result in our inability and the inability of our tenants to execute our respective business plans.

• New laws that are adverse to the business of our tenants may be enacted, and current favorable state or local laws relating to cultivation and production of medical-use cannabis may be modified or eliminated in the future.

•We are dependent on our key personnel for our success. The departure of any of our executive officers or key personnel could have a material adverse effect on our business.

• Our growth depends on external sources of capital, which may not be available on favorable terms or at all.

• Our real estate investments will consist of primarily industrial properties suitable for cultivation and production of medical-use cannabis, which may be difficult to sell or re-lease upon tenant defaults or early lease terminations, either of which would adversely affect returns to stockholders.

• Investors participating in this offering will incur immediate and substantial dilution.

• Our failure to qualify or remain qualified as a REIT would subject us to U.S. federal income tax and applicable state and local taxes, which would reduce the amount of cash available for distribution to our stockholders and may have significant adverse consequences on the market price of our Class A common stock.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

Subsidiary